By Lauren Berg ( March 28, 2022, 8:51 PM EDT) -- Illumina can permanently bar its Chinese rival BGI Genomics from further infringing soon-to-expire patents behind its next-generation genome-sequencing technology, but can't triple its $8 million in damages awarded by a jury that determined BGI willfully infringed four out of five of those patents, a California federal judge ruled Sunday....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.